Skip to Content

Residential Segregation May Worsen NSCLC Outcomes for Black Patients

FRIDAY, Feb. 5, 2021 -- Black patients are more likely to present with advanced non-small cell lung cancer (NSCLC) and are less likely to receive surgery at higher residential segregation levels, according to a study presented at the annual meeting of the Society of Thoracic Surgeons, held virtually from Jan. 29 to 31.

Chandler Annesi, from the Boston University School of Medicine, and colleagues examined racial disparities of NSCLC treatment and mortality outcomes in association with residential segregation. The exposure of interest was the index of dissimilarity (IoD), which is a validated proxy for structural racism. Data were included for 35,649 Black and 193,369 White patients with NSCLC from 2004 to 2016.

The researchers found that Black patients had an increased risk for presenting at an advanced stage (RR, 1.49), while for White patients, the risk for presenting at an advanced stage increased with increasing IoD (RR, 1.43). The likelihood of undergoing surgical resection was lower for Black patients (RR, 0.37); among Whites, the likelihood of undergoing surgical resection was reduced with increasing IoD (RR, 0.56). At low levels of segregation, disparities between Black and White patients were eliminated for both stage at diagnosis and the likelihood of surgical resection. For Black patients, median cancer-specific survival differed significantly at high and low IoD (10 versus 12 months). Median cancer-specific survival was 10 and 13 months for Black and White patients, respectively, at high IoD.

"As we show in our research, segregation, the resulting devaluation of black communities, and other downstream factors have led to wide disparities in lung cancer outcomes," Annesi said in a statement.

Press Release

More Information

© 2021 HealthDay. All rights reserved.

Posted: February 2021

Read this next

Model Can Aid Assessment of Multiple Pulmonary Nodules

THURSDAY, Feb. 25, 2021 -- A machine learning-based model has been developed and validated for predicting malignancy in multiple pulmonary nodules (MPNs), according to a study...

Disparities in Lung Cancer Screening Eligibility Still Exist

FRIDAY, Jan. 22, 2021 -- Despite increases in lung cancer screening eligibility, gender, racial, and ethnic screening disparities may still persist, according to a study published...

Pandemic Has Disrupted Lung Cancer Screenings

TUESDAY, Jan. 5, 2021 -- COVID-19 has caused significant disruption in lung cancer screening, according to a study published online Dec. 17 in the Journal of the American College...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.